Sulfathiazole+ Naphazoline nitrate
This medicine should always be used exactly as described in this package leaflet for the patient, or as directed by a doctor or pharmacist.
Sulfarinol nasal drops are a white, oily liquid containing two active substances
Before starting to use Sulfarinol, the patient should discuss it with their doctor or pharmacist if:
Do not use in children under 12 years of age.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Using medicines containing naphazoline in patients treated with tricyclic antidepressants may enhance their effect on blood vessels (increased constriction).
Concomitant use of MAO inhibitors may lead to a hypertensive crisis (sudden increase in blood pressure).
Sulfarinol can be used at any time, regardless of meals.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
Sulfarinol should not be used during pregnancy and breastfeeding, unless it is absolutely necessary. The decision can only be made by a doctor after assessing the expected benefit of treatment for the mother in relation to the risk to the fetus or breastfed child.
No studies have been conducted on the effect of the product on the ability to drive and use machines. The patient should be cautious and not perform such activities if side effects occur or they are particularly sensitive to the effect of the medicine.
1 ml of the medicinal product contains 0.16 mg of methyl parahydroxybenzoate (E 218) and 0.01 mg of propyl parahydroxybenzoate (E 216). The medicine may cause allergic reactions (possible late reactions).
This medicine should always be used exactly as described in this package leaflet for the patient, or as directed by a doctor or pharmacist. In case of doubts, the patient should consult their doctor or pharmacist.
The recommended dose for adults and children over 12 years of age is 1 to 2 drops every 4 to 6 hours into each nostril. The medicine should be instilled into each nostril on the nasal wing, then the nose should be pinched several times with the index finger and thumb. Shake before use.
The medicine should not be used more frequently than every 4 hours and not for more than 3 to 5 days.
The use of the medicine in adolescents over 12 years of age is in accordance with the adult dosage.
Sulfarinol should not be used in children under 12 years of age.
Using significantly higher doses than recommended may cause general side effects, such as increased blood pressure, nausea, pain, and dizziness, palpitations, drowsiness, and lethargy, slowing of heart rate, and Stevens-Johnson syndrome (fever and severe symptoms in the skin and mucous membranes of the nose and mouth). Significant overdose may lead to inhibition of the central nervous system with severe sedation, hypotension (shock), hypothermia, and coma, as well as sticking of the nasal mucosa cilia. This systemic effect is caused by the flow of excess drops into the stomach and absorption of the medicine into the bloodstream from the gastrointestinal tract. In such a case, the patient should immediately consult a doctor.
Prolonged use of higher doses than recommended for a longer period than recommended (more than 3 to 5 days) may cause permanent damage to the mucosa.
A double dose should not be used to make up for a missed dose.
Stopping the use of Sulfarinol prematurely may result in a lack of therapeutic effect and contribute to the development of resistance of bacterial strains to the medicine.
In case of any further doubts related to the use of this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Sulfarinol can cause side effects, although not everybody gets them.
Side effects that occur with proper use, as recommended in this leaflet, are very rare. Local side effects - allergic symptoms (skin rash, lip swelling) may occur in case of use (despite contraindications) in people allergic to sulfonamides. General side effects caused by naphazoline nitrate may occur after intranasal administration due to rapid absorption of the medicine through the inflamed mucosa and in case of overdose after incorrect instillation (when the medicine flowing into the stomach is absorbed from the gastrointestinal tract). This may also occur in case of use (despite contraindications) in children, mainly in the age group under 3 years.
Local side effects - allergic symptoms (skin rash, lip swelling) may occur in case of use (despite contraindications) in children under 12 years of age, especially in the age group under 7 years.
General side effects caused by naphazoline nitrate may occur after intranasal administration due to rapid absorption of the medicine through the inflamed mucosa and in case of overdose after incorrect instillation (when the medicine flowing into the stomach is absorbed from the gastrointestinal tract). This may also occur in case of use (despite contraindications) in children, mainly in the age group under 3 years.
If any side effects occur, including any side effects not listed in this leaflet, the patient should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
PL-02 222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will allow for more information to be collected on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 25°C in the original packaging to protect from light.
Do not use this medicine after the expiry date stated on the label. The expiry date refers to the last day of the specified month.
Medicines should not be disposed of via wastewater or household waste containers. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The immediate packaging of the medicine is a polyethylene bottle with a dropper. The bottle contains 20 ml of a white oily liquid.
TACTICA Pharmaceuticals Sp. z o.o.
ul. Królowej Jadwigi 148a/1a
30-212 Kraków
phone: +48 889 388 538
Farmaceutyczno-Chemiczna Spółdzielnia Pracy „GALENUS"
ul. Hutnicza 8; 03-791 Warsaw
phone: 022 6796921
phone/fax: 022 6792215
e-mail: marketing@galenus.pl
Date of last revision of the leaflet:11/2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.